Compare JRSH & ALPS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | JRSH | ALPS |
|---|---|---|
| Founded | 2016 | 2017 |
| Country | United States | Malaysia |
| Employees | N/A | N/A |
| Industry | Apparel | |
| Sector | Consumer Discretionary | |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 68.8M | 66.6M |
| IPO Year | 2017 | 2024 |
| Metric | JRSH | ALPS |
|---|---|---|
| Price | $5.82 | $0.37 |
| Analyst Decision | Strong Buy | |
| Analyst Count | 2 | 0 |
| Target Price | ★ $4.00 | N/A |
| AVG Volume (30 Days) | ★ 79.8K | 59.6K |
| Earning Date | 02-09-2026 | 07-24-2026 |
| Dividend Yield | ★ 5.68% | N/A |
| EPS Growth | ★ 485.71 | N/A |
| EPS | ★ 0.13 | N/A |
| Revenue | ★ $166,263,870.00 | N/A |
| Revenue This Year | $11.64 | N/A |
| Revenue Next Year | $10.06 | N/A |
| P/E Ratio | $45.38 | ★ N/A |
| Revenue Growth | ★ 14.03 | N/A |
| 52 Week Low | $2.85 | $0.23 |
| 52 Week High | $5.97 | $1.72 |
| Indicator | JRSH | ALPS |
|---|---|---|
| Relative Strength Index (RSI) | 60.95 | 46.12 |
| Support Level | $3.01 | $0.38 |
| Resistance Level | $5.81 | $0.44 |
| Average True Range (ATR) | 0.22 | 0.02 |
| MACD | 0.02 | 0.00 |
| Stochastic Oscillator | 83.50 | 34.34 |
Jerash Holdings (US) Inc along with its subsidiaries, is a manufacturer and exporter of customized, ready-made sport and outerwear from knitted fabric from its production facilities in Jordan. The company manufactures for retailers, including Walmart, Costco, Sears, Hanes, Columbia, Land's End, VF Corporation, and Philip-Van Heusen, which owns brands such as The North Face, Nautica, Timberland, Wrangler, Lee, Jansport, Calvin Klein, Tommy Hilfiger, IZOD, and Speedo. It derives its revenue from the manufacturing and sales of outerwear in the United States. The company's product offering consists of jackets, polo shirts, crew neck shirts, pants, and shorts made from knitted fabric. Geographically, the company generates maximum revenue from the United States.
ALPS Group Inc is an investment holding company involved in research and development, including stem cell and biotechnology-related business, and investing and managing businesses such as health and beauty centres and medical centres. The Company operates through Medical and Wellness, Life Science and Others segments. Medical and Wellness generates maximum revenue from non-surgical aesthetic services, surgical aesthetic services, medical consultation, health screenings, cellular therapy and research, and COVID-19 testing. Life Science provides whole-genome sequencing and pharmacogenomics, while Others comprises investment holding and provision of management services. The Company generates revenue in Malaysia.